Oct 16, 2024

chat

Remdesivir Papers: Drug Used to Treat Service Members Led to Death

What has been revealed in the “Remdesivir Papers” will shock you to the core. This compilation of documents, released by a military whistleblower, contains damning information on the hundreds of deaths and adverse events related to the clinical trials of a COVID antiviral. Besides the compromise on the fundamental issue of informed consent, these files reveal concerning truths related to the methodology and processing of the product testing data among servicemembers. Brad Miller gives viewers an in-depth analysis of this subject matter, today, on “Defender In-Depth.” Don’t miss it!

*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.

Resources

'Should Not Be Used in Any Infants': Higher Death Risk in Beyfortus RSV Shot Clinical Trials

Japan Approves World's First 'Self-amplifying' mRNA COVID Shot - Is the U.S. Next?

Lawyers for RFK Jr., CHD Present Oral Arguments in Landmark Censorship Case

'Shocking': Heavy Metals, Nearly 50 Pesticides Detected in School Lunches

'An Act of War': Big Food Intentionally Addicting Kids to Toxic Foods

Lobbyists for Pediatricians and Dentists Dig in on Water Fluoridation

Court Confirms Merck Lied on Mumps Vaccine Label - But Lets Drugmaker Off the Hook in Antitrust Lawsuit

Doctor Fired for Refusing COVID Shots Sues Tufts Medical Center

The Remdesivir Papers

The Remdesivir Papers: Did Service Members Deserve to Die? | The Gateway Pundit | by J.M. Phelps

Gilead Falsely Advertised Remdesivir as Safe and Effective, Lawsuit Alleges

Glass Particles Prompt Another Recall of Remdesivir, the Controversial Drug Hospitals Used to Treat COVID Patients

Witness to Tragedy: 'Huge' Financial Incentives Led Hospitals to Use COVID Treatments That Killed Patients

Exclusive: Survivor of CDC COVID Protocols Says She Was 'Just a Paycheck'

Exclusive: 'They Just Ran Roughshod Over My Parents'

EXCLUSIVE: Military Whistleblower Shares his Motivation for Releasing the Explosive "The Remdesivir Papers" Report | The Gateway Pundit | by J.M. Phelps

United States Patent: 9724360

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Defense Department Press Briefing Investigating and Developing Vaccine Candidates Against COVID-19

Army Signs Agreement With Drug Giant Gilead on Experimental COVID-19 Treatment

Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among Us Veterans Hospitalized With COVID-19

Study NCT04280705 [ACTT-1]

Study NCT04401579 [ACTT-2]

Study NCT04492475 [ACTT-3]

Study NCT04640168 [ACTT-4]

Expanded Access Remdesivir (RDV; GS-5734™) | ClinicalTrials.gov

Military Could Owe Billions to Service Members Involuntarily Discharged for Refusing COVID Shots

Lack of Informed Consent

Gilead Sciences | Open Secrets

The Public Already Has Paid for Remdesivir - Public Citizen

About the CARES Act and the Consolidated Appropriations Act

FOIA Request to the USAMRDC

Children's Health Defense Military Chapter

Bill Gates Thinks These 3 Coronavirus Drugs ‘Could Cut the Death Rate Dramatically'

Remdesivir, Developed Through a Unc-Chapel Hill Partnership, Proves Effective Against COVID-19 in Niaid Human Clinical Trials - UNC Gillings School of Global Public Health

The Military Recruiting Outlook Is Grim Indeed. Loss of Public Confidence, Political Attacks and the Economy Are All Taking a Toll

Related Videos